Viking Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. 

CEO
Brian Lian
CEOBrian Lian
Employees
36
Employees36
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2012
Founded2012
Employees
36
Employees36

VKTX Key Statistics

Market cap
2.91B
Market cap2.91B
Price-Earnings ratio
-22.52
Price-Earnings ratio-22.52
Dividend yield
Dividend yield
Average volume
4.29M
Average volume4.29M
High today
$26.94
High today$26.94
Low today
$24.34
Low today$24.34
Open price
$25.06
Open price$25.06
Volume
3.46M
Volume3.46M
52 Week high
$81.86
52 Week high$81.86
52 Week low
$18.92
52 Week low$18.92

VKTX News

Benzinga 5d
Viking Therapeutics Stock Dips After Q1 EPS Miss: Details

Viking Therapeutics, Inc. VKTX released its first-quarter results after Wednesday's closing bell. Here's a look at the details from the report. The Details: Vi...

Viking Therapeutics Stock Dips After Q1 EPS Miss: Details

Analyst ratings

89%

of 19 ratings
Buy
89.5%
Hold
10.5%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.